Literature DB >> 32633601

Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody.

Romain Deschamps1, Manon Philibert2, Cedric Lamirel3, Jerome Lambert4, Vivien Vasseur5, Antoine Gueguen1, Caroline Bensa1, Augustin Lecler6, Romain Marignier7, Catherine Vignal3, Olivier Gout1.   

Abstract

BACKGROUND: A paradoxical discrepancy between severe peripapillary retinal nerve fiber layer (pRNFL) atrophy and good visual outcome had been reported in patients with myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG)-associated optic neuritis (ON). However, only visual acuity (VA) was assessed.
OBJECTIVES: To study visual field (VF) outcomes of patients with MOG-IgG-associated ON and evaluate the correlation between functional eye outcome and retinal structural changes assessed by optical coherence tomography.
METHODS: The records of 32 patients with MOG-IgG-associated ON who underwent ophthalmological examination at least 12 months after ON onset were reviewed. Degree of VF disability was determined by mean deviation (MD).
RESULTS: At final assessment (median, 35 months), 4.2% of 48 affected eyes (AE) had VA ⩽ 0.1, 40% had abnormal MD, and among AE with final VA ⩾ 1.0, 31% had mild to moderate damage. Thinning of the inner retinal layers was significantly correlated with MD impairment. Analysis demonstrated a threshold of pRNFL thickness (50 µm), below which MD was significantly worse (mean, -2.27 dB vs -17.72 dB; p = 0.0003). ON relapse was significantly associated with poor visual outcome assessed by MD.
CONCLUSION: Functional impairment measured with VF is not rare, and MD assessment better reflects actual structural damage.

Entities:  

Keywords:  Optic neuritis; myelin oligodendrocyte glycoprotein; optic coherence tomography; visual field

Year:  2020        PMID: 32633601     DOI: 10.1177/1352458520937281

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  3 in total

Review 1.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.

Authors:  Elia Sechi; Laura Cacciaguerra; John J Chen; Sara Mariotto; Giulia Fadda; Alessandro Dinoto; A Sebastian Lopez-Chiriboga; Sean J Pittock; Eoin P Flanagan
Journal:  Front Neurol       Date:  2022-06-17       Impact factor: 4.086

2.  Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.

Authors:  Alexander U Brandt; Hanna G Zimmermann; Norman K Gigengack; Frederike C Oertel; Seyedamirhosein Motamedi; Charlotte Bereuter; Ankelien Duchow; Rebekka Rust; Judith Bellmann-Strobl; Klemens Ruprecht; Tanja Schmitz-Hübsch; Friedemann Paul
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

3.  Structural and functional differentiation between compressive and glaucomatous optic neuropathy.

Authors:  Poramaet Laowanapiban; Kanchalika Sathianvichitr; Niphon Chirapapaisan
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.